Clinical Labs, Victorious in Squelching Healthcare Reform Tax, Promote PGx-Based Cost Savings
September 30, 2009
Clinical Labs, Victorious in Squelching Healthcare Reform Tax, Promote PGx-Based Cost Savings
The US Senate Finance Committee chairman's proposed $750 million tax on clinical labs has been dropped. But as the healthcare reform debate rages, industry stakeholders are highlighting less draconian ways for the clinical lab sector to reduce healthcare costs, such as personalized medicine and prevention strategies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Court Approves Sale of Correlogic’s Assets to Vermillion after Second Bidder Drops Out
December 2, 2011 / ProteoMonitor - Is Healthlinx Eyeing Purchase of Correlogic's Assets as Part of Move into US Cancer Dx Market?
October 14, 2011 / ProteoMonitor - Correlogic Developing 'Second Generation' OvaCheck; Seeks Ruling on Quest, LabCorp Licenses
July 8, 2011 / ProteoMonitor - Auction of Correlogic's Assets Pushed Back to Give Potential Buyers Time for Due Diligence
June 17, 2011 / ProteoMonitor - Date, Minimum Bids Set for Sale of Correlogic's Assets
May 27, 2011 / ProteoMonitor